Cargando…
Preclinical Evaluation of a Protein-Based Nanoscale Contrast Agent for MR Angiography at an Ultralow Dose
PURPOSE: BSA-biomineralized Gd nanoparticles (Gd@BSA NPs) have been recognized as promising nanoscale MR contrast agents. The aim of this study was to carry out a preclinical evaluation of these NPs in a middle-sized animal model (rabbits). METHODS: New Zealand white rabbits were treated intravenous...
Autores principales: | Li, Jianmin, Zhang, Wenyi, Liu, Shuang, Yang, Fan, Zhou, Yupeng, Cao, Lin, Li, Yiming, Guo, Yunfei, Qi, Xiang, Xu, Guoping, Peng, Jing, Zhao, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404595/ https://www.ncbi.nlm.nih.gov/pubmed/37555188 http://dx.doi.org/10.2147/IJN.S416741 |
Ejemplares similares
-
Reducing Contrast Agent Dose in Cardiovascular MR Angiography with Deep Learning
por: Montalt‐Tordera, Javier, et al.
Publicado: (2021) -
Nanoscale Coatings for Ultralow Dose BMP‐2‐Driven Regeneration of Critical‐Sized Bone Defects
por: Cheng, Zhe A., et al.
Publicado: (2018) -
Whole heart 3 D MR coronary angiography with and without extracellular contrast agent
por: Piotrowska-Kownacka, Dorota, et al.
Publicado: (2009) -
Improving the sensitivity of T(1) contrast-enhanced MRI and sensitive diagnosing tumors with ultralow doses of MnO octahedrons
por: Yang, Lijiao, et al.
Publicado: (2021) -
Nanoscale Contrast Agents for Ultrasound Imaging of Musculoskeletal System
por: Tang, Xiaoyi, et al.
Publicado: (2022)